Literature DB >> 16265602

Tissue Doppler echocardiography in evaluation of cardiac effects of subclinical hypothyroidism.

Huseyin Arinc1, Huseyin Gunduz, Ali Tamer, Ergun Seyfeli, Mustafa Kanat, Hakan Ozhan, Ramazan Akdemir, Cihangir Uyan.   

Abstract

OBJECTIVE: Subclinical hypothyroidism (SH) is a mild form of thyroid failure, associated with initial signs of cardiovascular hypothyroidism. Tissue Doppler echocardiography (TDE) is a new and powerful method in evaluation of both regional and global systolic or diastolic ventricular function. We aimed to investigate the use of TDE in evaluation of cardiac effects of SH and affect of thyroid hormone replacement therapy (TRT) on tissue Doppler parameters of SH patients.
METHODS: Twenty-two patients who were diagnosed as SH and 22 healthy, age and sex-matched cases were included in the study. Conventional echocardiography and TDE were performed in all individuals. TRT was started in SH group. On the achievement of euthyroid state echocardiography were repeated.
RESULTS: Septal annulus relaxation time was significantly higher in SH group (82+/-21, 98+/-11 ms, p=0.024). Lateral annulus and myocardial relaxation times, precontraction/contraction ratios and precontraction times were also slightly higher. Septal lateral annulus and lateral myocardial relaxation times were decreased after TRT (98+/-11 vs. 81+/-12, p<0.001, 89+/-14 vs. 78+/-11, p=0.022, 90+/-16 vs. 80+/-14 ms, p=0.008, respectively). Precontraction times and precontraction/contraction ratios decreased after TRT but did not reach the significance level. There was a positive correlation between TSH and TDE relaxation times.
CONCLUSIONS: TDE is a powerful tool in diagnosis and follow-up of SH patients and TRT inhibits adverse affects of SH on myocardium. Septal myocardium is the most affected region of left ventricle in SH. The relaxation time is the best criteria of cardiac involvement and monitoring the effect of TRT.

Entities:  

Mesh:

Year:  2005        PMID: 16265602     DOI: 10.1007/s10554-005-9030-2

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  28 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

Review 2.  Clinical applications of strain rate imaging.

Authors:  Gabriel Yip; Theodore Abraham; Marek Belohlavek; Bijoy K Khandheria
Journal:  J Am Soc Echocardiogr       Date:  2003-12       Impact factor: 5.251

Review 3.  Thyroid disease and its treatment: short-term and long-term cardiovascular consequences.

Authors:  F Osman; M D Gammage; J A Franklyn
Journal:  Curr Opin Pharmacol       Date:  2001-12       Impact factor: 5.547

4.  A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism.

Authors:  E Nyström; K Caidahl; G Fager; C Wikkelsö; P A Lundberg; G Lindstedt
Journal:  Clin Endocrinol (Oxf)       Date:  1988-07       Impact factor: 3.478

5.  Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study.

Authors:  A E Hak; H A Pols; T J Visser; H A Drexhage; A Hofman; J C Witteman
Journal:  Ann Intern Med       Date:  2000-02-15       Impact factor: 25.391

Review 6.  Biochemical basis of thyroid hormone action in the heart.

Authors:  W H Dillmann
Journal:  Am J Med       Date:  1990-06       Impact factor: 4.965

Review 7.  Subclinical hypothyroidism and cardiac function.

Authors:  Bernadette Biondi; Emiliano A Palmieri; Gaetano Lombardi; Serafino Fazio
Journal:  Thyroid       Date:  2002-06       Impact factor: 6.568

8.  [Influence of congenital hypothyroidism on left ventricular function of neonates].

Authors:  Shan-shan Mao; Zheng-yan Zhao; Guo-ping Jiang
Journal:  Zhonghua Er Ke Za Zhi       Date:  2004-07

9.  Usefulness of pulsed tissue Doppler for the assessment of left ventricular myocardial function in overt hypothyroidism.

Authors:  Maurizio Galderisi; Giovanni Vitale; Arcangelo D'Errico; Gelsy Arianna Lupoli; Antonio Ciccarelli; Silvana Cicala; Moira Pardo; Giovanni Lupoli; Oreste de Divitiis
Journal:  Ital Heart J       Date:  2004-04

10.  Concurrent aortic and mitral valve echocardiography permits measurement of systolic time intervals as an index of peripheral tissue thyroid functional status.

Authors:  K H Tseng; P G Walfish; J A Persaud; B W Gilbert
Journal:  J Clin Endocrinol Metab       Date:  1989-09       Impact factor: 5.958

View more
  6 in total

1.  Tissue Doppler imaging--a sensible imaging option for the sensitive heart.

Authors:  Yat-Yin Lam; Wei Li; Michael Y Henein
Journal:  Int J Cardiovasc Imaging       Date:  2006-03-31       Impact factor: 2.357

2.  The association of presystolic wave with subclinical left-ventricular dysfunction in patients with subclinical hypothyroidism.

Authors:  Faysal Saylik; Tayyar Akbulut
Journal:  J Echocardiogr       Date:  2021-10-11

3.  Effects of levothyroxine therapy on left and right ventricular function in neonates with congenital hypothyroidism: a tissue Doppler echocardiography study.

Authors:  Shanshan Mao; Yanxia Wang; Guoping Jiang; Zhengyan Zhao
Journal:  Eur J Pediatr       Date:  2007-02-15       Impact factor: 3.183

4.  The effect of L-thyroxine treatment on hypothyroid symptom scores and lipid profile in children with subclinical hypothyroidism.

Authors:  Gönül Çatlı; Ahmet Anık; Hale Ünver Tuhan; Ece Böber; Ayhan Abacı
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014-12

5.  Left and right ventricular structure and function in subclinical hypothyroidism: the effects of one-year levothyroxine treatment.

Authors:  Sanja Ilic; Marijana Tadic; Branislava Ivanovic; Zorica Caparevic; Bozo Trbojevic; Vera Celic
Journal:  Med Sci Monit       Date:  2013-11-10

6.  No association between subclinical hypothyroidism and dyslipidemia in children and adolescents.

Authors:  Ashkan Habib; Asadollah Habib
Journal:  BMC Pediatr       Date:  2020-09-16       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.